US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Lantern Pharma Inc.

3.39

+0.28009.00%

Volume:19.03K

Turnover:62.84K

Market Cap:36.56M

PE:-1.76

High:3.50

Open:3.14

Low:3.07

Close:3.11

Loading ...

Overview Company News Filings

Lantern Pharma Inc. (LTRN) Receives Second FDA Fast Track Designation for LP-184 in Triple Negative Breast Cancer

Lantern Pharma Shares Rise After Fast-Track Designation for Cancer Treatment

BUZZ-Lantern Pharma rises on FDA 'fast track' tag for breast cancer drug

Lantern Pharma granted fast track designation for LP-184

Lantern Pharma's Investigational Drug-Candidate, Lp-184, Receives Second Fast Track Designation From FDA for Treatment of Triple Negative Breast Cancer (Tnbc)

THOMSON REUTERS

Lantern Pharma's Investigational Drug-Candidate, LP-184, Receives Second Fast Track Designation from FDA for Treatment of Triple Negative Breast Cancer (TNBC)

BRIEF-Lantern Pharma & Starlight Therapeutics Present LP-184

Lantern Pharma & Starlight Therapeutics Present Lp-184 (Star-001) Phase 1B Trial Design and Preclinical Data in Glioblastoma at Society for Neuro-Oncology (Sno) 2024 Highlighting Novel Synthetic Lethality

THOMSON REUTERS

Lantern Pharma & Starlight Therapeutics Present LP-184 (STAR-001) Phase 1b Trial Design and Preclinical Data in Glioblastoma at Society for Neuro-Oncology (SNO) 2024 Highlighting Novel Synthetic Lethality

BRIEF-Lantern Pharma Announces First Patient Dosed In Japan

Lantern Pharma doses first patient in LP-300 trial expansion cohort

Lantern Pharma Announces First Patient Dosed in Japan for the Expansion Cohort in the Phase 2 Harmonic™ Clinical Trial of Lp-300 in Never-Smoker Nsclc Patients

THOMSON REUTERS

Lantern Pharma Announces First Patient Dosed in Japan for The Expansion Cohort in The Phase 2 HARMONIC™ Clinical Trial of LP-300 in Never-Smoker NSCLC Patients

LTRN: Pediatric Rare Cancer in Focus

Zacks Small Cap Research

Lantern Pharma Inc (LTRN) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Rising ...

Lantern Pharma Discusses Q3 Financial Results Webinar

Lantern Pharma Inc reports results for the quarter ended in September 30 - Earnings Summary

Lantern Pharma Q3 2024 GAAP EPS $(0.42) Beats $(0.56) Estimate

Lantern Pharma Inc expected to post a loss of 56 cents a share - Earnings Preview

BRIEF-Starlight Therapeutics Announces Inaugural Members Of Scientific Advisory Board

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/LTRN/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LTRN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LTRN\",,,,,undefined,":{"symbol":"LTRN","market":"US","secType":"STK","nameCN":"Lantern Pharma Inc.","latestPrice":3.39,"timestamp":1745344248656,"preClose":3.11,"halted":0,"volume":19032,"delay":0,"floatShares":7963676,"shares":10784725,"eps":-1.930923,"marketStatus":"Trading","change":0.28,"latestTime":"04-22 14:05:31 EDT","open":3.14,"high":3.5,"low":3.07,"amount":62839.7129568,"amplitude":0.138264,"askPrice":3.5,"askSize":701,"bidPrice":3.39,"bidSize":10,"shortable":0,"etf":0,"ttmEps":-1.930923,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1745352000000},"marketStatusCode":2,"adr":0,"listingDate":1591848000000,"exchange":"NASDAQ","adjPreClose":3.11,"postHourTrading":{"tag":"盘后","latestPrice":3.11,"preClose":3.11,"latestTime":"17:06 EDT","volume":120,"amount":372.24,"timestamp":1745269605280},"volumeRatio":0.676378,"impliedVol":0.7058,"impliedVolPercentile":0.564},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LTRN\",,,,,undefined,":{"symbol":"LTRN","floatShares":7963676,"roa":"-40.12%","roe":"-66.93%","lyrEps":-1.930923,"volumeRatio":0.676378,"shares":10784725,"dividePrice":0,"high":3.5,"amplitude":0.138264,"preClose":3.11,"low":3.07,"week52Low":2.55,"pbRate":"1.73","week52High":7.21,"institutionHeld":0,"latestPrice":3.39,"committee":-0.971871,"eps":-1.930923,"divideRate":0,"volume":19032,"delay":0,"ttmEps":-1.930923,"open":3.14,"prevYearClose":3.19,"prevWeekClose":3.42,"prevMonthClose":3.54,"prevQuarterClose":3.54,"fiveDayClose":3.53,"twentyDayClose":3.9,"sixtyDayClose":5.4},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LTRN\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2489212506","title":"Lantern Pharma Inc. (LTRN) Receives Second FDA Fast Track Designation for LP-184 in Triple Negative Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2489212506","media":"Insider Monkey","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489212506?lang=en_us&edition=fundamental","pubTime":"2024-12-07 14:59","pubTimestamp":1733554762,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 15 AI News Updates That Broke The Internet.In this article, we are going to take a look at where Lantern Pharma Inc.  stands against the other AI stocks that broke the Internet recently.With Trump taking in the reigns soon, steps toward overhauling the US policy have begun. President-elect Trump said on Thursday that he is appointing former Pay Pal Chief Operating Officer David Sacks as his \"White House A.I. & Crypto Czar”.READ NOW:15 AI News Investors Shouldn’t Missand15 Buzzing AI Stocks Making Headlines. “As AI becomes more advanced, it will solve increasingly complex and critical problems. It also takes significantly more compute to power these capabilities”.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/GkjOxHwY5KwIxtZycd1dPQ--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/f570aae28e1052f5a4a089428411fb02","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/GkjOxHwY5KwIxtZycd1dPQ--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/f570aae28e1052f5a4a089428411fb02"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lantern-pharma-inc-ltrn-receives-065922770.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["FAST","BK4104","IE00BFXG0V08.USD","BK4588","LTRN","IE00B5TLWC47.USD","BK4567","BK4585","BK4139","IE00BYQQ9H92.USD"],"gpt_icon":0},{"id":"2488966941","title":"Lantern Pharma Shares Rise After Fast-Track Designation for Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2488966941","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488966941?lang=en_us&edition=fundamental","pubTime":"2024-12-03 23:16","pubTimestamp":1733238960,"startTime":"0","endTime":"0","summary":"Lantern Pharma shares were up 6% to $3.34 after the company said the Food and Drug Administration has granted fast-track designation for the investigational drug candidate LP-184 for the treatment of triple negative breast cancer.Shares of the medical AI company hit their 52-week low of $2.79 on Nov. 21, and are down 11% in the past 12 months.This is the second fast-track designation received for LP-184 in 2024, following its designation for glioblastoma in October.The Dallas company said LP-184 is currently in a Phase 1A clinical trial designed to evaluate its safety and tolerability in a broad range of solid tumors.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B5TLWC47.USD","IE00BYQQ9H92.USD","BK4139","BK4567","FAST","IE00BFXG0V08.USD","LTRN","BK4585","BK4104","BK4588"],"gpt_icon":0},{"id":"2488910368","title":"BUZZ-Lantern Pharma rises on FDA 'fast track' tag for breast cancer drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2488910368","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488910368?lang=en_us&edition=fundamental","pubTime":"2024-12-03 21:43","pubTimestamp":1733233401,"startTime":"0","endTime":"0","summary":"** Shares of cancer drug developer Lantern Pharma    rise ~15% to $3.63 premarket   ** LTRN says the U.S. Food and Drug Administration has granted \"fast track\" designation to its experimental drug to treat a type of breast cancer called triple negative breast cancer    ** The drug, LP-184, showed preclinical efficacy in treating TNBC - LTRN    ** FDA's \"fast track\" status expedites the review of medicines to treat serious conditions   ** As of last close, stock has fallen 26.2% YTD ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"BUZZ-Lantern Pharma rises on FDA 'fast track' tag for breast cancer drug","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LTRN","BK4139"],"gpt_icon":0},{"id":"2488291272","title":"Lantern Pharma granted fast track designation for LP-184","url":"https://stock-news.laohu8.com/highlight/detail?id=2488291272","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488291272?lang=en_us&edition=fundamental","pubTime":"2024-12-03 21:11","pubTimestamp":1733231514,"startTime":"0","endTime":"0","summary":"Lantern Pharma (LTRN) announced that the FDA has granted Fast Track Designation for investigational drug candidate, LP-184, for treatment of Triple...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lantern-pharma-granted-fast-track-designation-for-lp-184-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lantern-pharma-granted-fast-track-designation-for-lp-184-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LTRN","BK4588","IE00BYQQ9H92.USD","IE00B5TLWC47.USD","BK4585","IE00BFXG0V08.USD","FAST","BK4104","BK4567","BK4139"],"gpt_icon":0},{"id":"2488914488","title":"Lantern Pharma's Investigational Drug-Candidate, Lp-184, Receives Second Fast Track Designation From FDA for Treatment of Triple Negative Breast Cancer (Tnbc)","url":"https://stock-news.laohu8.com/highlight/detail?id=2488914488","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488914488?lang=en_us&edition=fundamental","pubTime":"2024-12-03 21:00","pubTimestamp":1733230805,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241203:nTUAYTZXN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LTRN","BK4139"],"gpt_icon":0},{"id":"2488914702","title":"Lantern Pharma's Investigational Drug-Candidate, LP-184, Receives Second Fast Track Designation from FDA for Treatment of Triple Negative Breast Cancer (TNBC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2488914702","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488914702?lang=en_us&edition=fundamental","pubTime":"2024-12-03 21:00","pubTimestamp":1733230800,"startTime":"0","endTime":"0","summary":"LP-184 demonstrated tumor regression of 107-141% in multiple TNBC PDX models. . This is the second Fast Track Designation granted to LP-184 in 2024, following the designation for Glioblastoma  announced in October 2024.Fast Track Designation for LP-184 recognizes TNBC as a serious condition impacting approximately 29,000 patients annually in the US, with over 50% of patients relapsing within 3-5 years.LP-184 has demonstrated significant preclinical efficacy in TNBC models, including those resistant to PARP inhibitors, and recent data shows promising synergy with checkpoint inhibitors in TNBC.TNBC represents approximately 20% of all breast cancers, affecting nearly 29,000 patients annually in the US. The prognosis for TNBC patients is considerably worse than hormone receptor-positive breast cancers, with over 50% of patients relapsing in the first 3-5 years and metastatic TNBC patients having a median overall survival of less than one year. Currently available treatment options are limi","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/McHB8q6EmIY0lk58suf_wA--~B/aD00ODA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/973dfeeee1c6c14a83bb08bab06a0668","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/McHB8q6EmIY0lk58suf_wA--~B/aD00ODA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/973dfeeee1c6c14a83bb08bab06a0668"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lantern-pharmas-investigational-drug-candidate-130000471.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4080","BK4104","IE00BFXG0V08.USD","IE00B5TLWC47.USD","BK4231","ML","PDX","BK4567","FAST","BK4139","BK4588","LTRN","IE00BYQQ9H92.USD","BK4585","BK4166","ADC"],"gpt_icon":0},{"id":"2486900352","title":"BRIEF-Lantern Pharma & Starlight Therapeutics Present LP-184","url":"https://stock-news.laohu8.com/highlight/detail?id=2486900352","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486900352?lang=en_us&edition=fundamental","pubTime":"2024-11-26 21:46","pubTimestamp":1732628793,"startTime":"0","endTime":"0","summary":"BRIEF-Lantern Pharma & Starlight Therapeutics Present LP-184Nov 26 (Reuters) - Lantern Pharma Inc LTRN.O:LANTERN PHARMA & STARLIGHT THERAPEUTICS PRESENT LP-184 (STAR-001) PHASE 1B TRIAL DESIGN AND PRE","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241126:nTUA2HMC9F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LTRN","BK4139"],"gpt_icon":0},{"id":"2486035330","title":"Lantern Pharma & Starlight Therapeutics Present Lp-184 (Star-001) Phase 1B Trial Design and Preclinical Data in Glioblastoma at Society for Neuro-Oncology (Sno) 2024 Highlighting Novel Synthetic Lethality","url":"https://stock-news.laohu8.com/highlight/detail?id=2486035330","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486035330?lang=en_us&edition=fundamental","pubTime":"2024-11-26 21:45","pubTimestamp":1732628700,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241126:nTUA2HMC9F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LTRN"],"gpt_icon":0},{"id":"2486005432","title":"Lantern Pharma & Starlight Therapeutics Present LP-184 (STAR-001) Phase 1b Trial Design and Preclinical Data in Glioblastoma at Society for Neuro-Oncology (SNO) 2024 Highlighting Novel Synthetic Lethality","url":"https://stock-news.laohu8.com/highlight/detail?id=2486005432","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486005432?lang=en_us&edition=fundamental","pubTime":"2024-11-26 21:45","pubTimestamp":1732628700,"startTime":"0","endTime":"0","summary":"The Phase 1b clinical trial design presented at SNO2024 combines LP-184  with spironolactone to potentially enhance therapeutic response in recurrent glioblastoma  patients.Preclinical data, including in previously published research by Lantern Pharma, demonstrates up to 6-fold increase in GBM cell sensitivity when LP-184 is combined with spironolactone.The clinical development for LP-184 in CNS cancers is planned to be advanced as STAR-001 by Starlight Therapeutics in later stage human clinical trials.The poster presentation highlighted LP-184's unique mechanism of action, brain penetrance properties, and potential enhanced therapeutic effect when combined with spironolactone in glioblastoma multiforme . LP-184 is currently under investigation in a Phase 1a dose-escalation safety study  in adult patients with advanced solid tumors including GBM.Preclinical studies show spironolactone increases GBM cell sensitivity to LP-184 up to 6-fold through ERCC3 degradation – which induces NERD  ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/jKX7AND1_9UFj7U4dqCxUg--~B/aD02MTU7dz0yMDM0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/71db1cc7d46eb00b91e123db19fc71f5","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/jKX7AND1_9UFj7U4dqCxUg--~B/aD02MTU7dz0yMDM0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/71db1cc7d46eb00b91e123db19fc71f5"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lantern-pharma-starlight-therapeutics-present-134500541.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LENZ","BK4139","ADC","BK4548","LU2413666426.HKD","BK4585","LU0347712357.USD","BK4231","LU2413666699.HKD","MTD","BK4588","BK4080","BK4533","LTRN","LU1721428933.USD","BK4121","LU1093756325.SGD","BK4567","LU1093756168.USD"],"gpt_icon":0},{"id":"2484820941","title":"BRIEF-Lantern Pharma Announces First Patient Dosed In Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2484820941","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484820941?lang=en_us&edition=fundamental","pubTime":"2024-11-19 21:23","pubTimestamp":1732022634,"startTime":"0","endTime":"0","summary":"Nov 19 (Reuters) - Lantern Pharma Inc   :   * LANTERN PHARMA ANNOUNCES FIRST PATIENT DOSED IN JAPAN FOR THE EXPANSION COHORT IN THE PHASE 2 HARMONIC™ CLINICAL TRIAL OF LP-300 IN NEVER-SMOKER NSCLC PATIENTSSource text:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LTRN","BK4139"],"gpt_icon":0},{"id":"2484941415","title":"Lantern Pharma doses first patient in LP-300 trial expansion cohort","url":"https://stock-news.laohu8.com/highlight/detail?id=2484941415","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484941415?lang=en_us&edition=fundamental","pubTime":"2024-11-19 21:21","pubTimestamp":1732022476,"startTime":"0","endTime":"0","summary":"Lantern Pharma (LTRN) announced that the first patient has been dosed – as part of the expansion cohort – in Japan for its Phase 2 Harmonic clinica...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lantern-pharma-doses-first-patient-in-lp-300-trial-expansion-cohort?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lantern-pharma-doses-first-patient-in-lp-300-trial-expansion-cohort?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LTRN","BK4139"],"gpt_icon":0},{"id":"2484794614","title":"Lantern Pharma Announces First Patient Dosed in Japan for the Expansion Cohort in the Phase 2 Harmonic™ Clinical Trial of Lp-300 in Never-Smoker Nsclc Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2484794614","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484794614?lang=en_us&edition=fundamental","pubTime":"2024-11-19 21:00","pubTimestamp":1732021205,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241119:nTUA6XVBT4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LTRN"],"gpt_icon":0},{"id":"2484941631","title":"Lantern Pharma Announces First Patient Dosed in Japan for The Expansion Cohort in The Phase 2 HARMONIC™ Clinical Trial of LP-300 in Never-Smoker NSCLC Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2484941631","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484941631?lang=en_us&edition=fundamental","pubTime":"2024-11-19 21:00","pubTimestamp":1732021200,"startTime":"0","endTime":"0","summary":"Ten clinical trial sites across Japan and Taiwan are actively screening patients, with additional sites expected to also begin patient enrollment in the coming months. U.S. clinical sites continue to actively screen and dose patients in both the LP-300 combination arm and the standard-of-care control arm of the Harmonic trial. Non-small cell lung cancer  in never smokers occurs at rates 2 to 3 times higher in East Asian countries versus the US and Europe.The expansion into Japan and Taiwan follows encouraging preliminary results from the U.S. trial's initial safety lead-in cohort, which demonstrated an 86% clinical benefit rate and 43% objective response rate among the first seven patients. The HARMONIC trial is evaluating LP-300 in combination with carboplatin and pemetrexed in never-smoker NSCLC patients who have recurrent NSCLC and have stopped responding to tyrosine kinase","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Jn2dGYxrgTwbdxzBe2YGHQ--~B/aD00ODA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/42e598300bf9a8e0896ef760cd6f518f","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Jn2dGYxrgTwbdxzBe2YGHQ--~B/aD00ODA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/42e598300bf9a8e0896ef760cd6f518f"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lantern-pharma-announces-first-patient-130000068.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4211","BK4080","BK4195","ADC","OS","HLIT","LTRN","BK4020","PFS","BK4231","ML","BK4097","BK4139","BK4166"],"gpt_icon":1},{"id":"2482408504","title":"LTRN: Pediatric Rare Cancer in Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2482408504","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482408504?lang=en_us&edition=fundamental","pubTime":"2024-11-12 16:00","pubTimestamp":1731398400,"startTime":"0","endTime":"0","summary":"Lantern Pharma, Inc  reported third quarter 2024 financial results and achievements in a November 7th, 2024 press release. Since our previous report, the company has been granted three additional rare pediatric disease designations for LP-184, and Fast Track designation for glioblastoma. It has also announced inaugural members for Starlight Therapeutics’ Scientific Advisory Board and participated in several conferences and presentations.On November 7th, 2024, Lantern announced third quarter 2024 financial and operational results, filed its Form 10-Q with the SEC and hosted a video webcast to review accomplishments. In the financial sphere, Lantern generated no revenues in 3Q:24 and incurred operating expense of $5.2 million, producing a net loss of  million or  per share.Lantern gained additional rare pediatric disease designations  for LP-184 in malignant rhabdoid tumors, rhabdomyosarcoma and hepatoblastoma as detailed in a September 2024 press release. This builds on the RPDD that wa","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/SFU9SgeP1hJUVPuTKXC27g--~B/aD0yODg7dz0xMDg4O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/scr.zacks.com/790a54c3a6e881f9baf186fea2666bf8","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/SFU9SgeP1hJUVPuTKXC27g--~B/aD0yODg7dz0xMDg4O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/scr.zacks.com/790a54c3a6e881f9baf186fea2666bf8"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ltrn-pediatric-rare-cancer-focus-080000275.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MRT","BK4230","BK4231","ADC","LTRN","BK4080","BK4139"],"gpt_icon":0},{"id":"2482846330","title":"Lantern Pharma Inc (LTRN) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Rising ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2482846330","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482846330?lang=en_us&edition=fundamental","pubTime":"2024-11-09 07:03","pubTimestamp":1731106995,"startTime":"0","endTime":"0","summary":"Net Loss: Approximately $4.5 million for Q3 2024, or $0.42 per share, compared to $3.2 million or $0.29 per share for Q3 2023.R&D Expenses: Approximately $3.7 million for Q3 2024, up from $2.2 million for Q3 2023.General and Administrative Expenses: Approximately $1.5 million for Q3 2024, up from $1.3 million for Q3 2023.Interest and Other Income: Approximately $674,000 for Q3 2024, compared to $362,000 for Q3 2023.Cash Position: Approximately $28.1 million as of September 30, 2024.Shares Outstanding: 10,784,725 shares of common stock as of September 30, 2024.Fully Diluted Shares Outstanding: Approximately 12.1 million shares as of September 30, 2024.GuruFocus has detected 1 Warning Sign with LTRN.For the complete transcript of the earnings call, please refer to the full earnings call transcript.Lantern Pharma Inc  has made significant clinical progress with its AI-guided drug programs, including the ongoing Phase 2 HARMONIC trial and Phase 1 programs for LP-184 and LP-284.The company ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/sza8Q4PaDzxjRXS41qCh6A--~B/aD0zNzA7dz0zNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/163900161d431648545a658aef18c1ed","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/sza8Q4PaDzxjRXS41qCh6A--~B/aD0zNzA7dz0zNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/163900161d431648545a658aef18c1ed"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lantern-pharma-inc-ltrn-q3-230315213.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LTRN"],"gpt_icon":0},{"id":"2481178126","title":"Lantern Pharma Discusses Q3 Financial Results Webinar","url":"https://stock-news.laohu8.com/highlight/detail?id=2481178126","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481178126?lang=en_us&edition=fundamental","pubTime":"2024-11-08 19:28","pubTimestamp":1731065337,"startTime":"0","endTime":"0","summary":"Lantern Pharma ( ($LTRN) ) just unveiled an update. On November 7, 2024, the Company hosted a conference call and live webinar to discuss its third...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lantern-pharma-discusses-q3-financial-results-webinar?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lantern-pharma-discusses-q3-financial-results-webinar?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LTRN","BK4139"],"gpt_icon":0},{"id":"2481192589","title":"Lantern Pharma Inc reports results for the quarter ended in September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2481192589","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481192589?lang=en_us&edition=fundamental","pubTime":"2024-11-08 12:25","pubTimestamp":1731039958,"startTime":"0","endTime":"0","summary":"Lantern Pharma Inc reports results for the quarter ended in September 30 - Earnings Summary  Lantern Pharma Inc LTRN.OQ reported a quarterly adjusted loss of 42 cents per share for the quarter ended S","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nL8N3MF093:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LTRN"],"gpt_icon":0},{"id":"2481515150","title":"Lantern Pharma Q3 2024 GAAP EPS $(0.42) Beats $(0.56) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2481515150","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481515150?lang=en_us&edition=fundamental","pubTime":"2024-11-08 05:40","pubTimestamp":1731015625,"startTime":"0","endTime":"0","summary":"Lantern Pharma (NASDAQ:LTRN) reported quarterly losses of $(0.42) per share which beat the analyst consensus estimate of $(0.56) by 25 percent.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/41826096/lantern-pharma-q3-2024-gaap-eps-0-42-beats-0-56-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Lantern Pharma Q3 2024 GAAP EPS $(0.42) Beats $(0.56) Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LTRN"],"gpt_icon":0},{"id":"2481612182","title":"Lantern Pharma Inc    expected to post a loss of 56 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2481612182","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481612182?lang=en_us&edition=fundamental","pubTime":"2024-11-06 13:06","pubTimestamp":1730869616,"startTime":"0","endTime":"0","summary":"* Lantern Pharma Inc     is expected to show no change in quarterly revenue when it reports  results on November 7 for the period ending September 30 2024   *    * LSEG's mean analyst estimate for Lan","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Lantern Pharma Inc    expected to post a loss of 56 cents a share - Earnings Preview","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LTRN"],"gpt_icon":0},{"id":"2481857509","title":"BRIEF-Starlight Therapeutics Announces Inaugural Members Of Scientific Advisory Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2481857509","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481857509?lang=en_us&edition=fundamental","pubTime":"2024-11-05 21:14","pubTimestamp":1730812477,"startTime":"0","endTime":"0","summary":"Nov 5 (Reuters) - Lantern Pharma Inc   :   * STARLIGHT THERAPEUTICS ANNOUNCES INAUGURAL MEMBERS OF SCIENTIFIC ADVISORY BOARDSource text:    Further company coverage:    (Reuters.Briefs@thomsonreuters.com)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","LTRN","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":43,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LTRN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-27","symbol":"LTRN","fiscalQuarterEnding":"2024/12","expectedEps":-0.51,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1743048000000,"reportTimeType":"post","actualEps":-0.54},{"market":"US","date":"2024-11-07","symbol":"LTRN","fiscalQuarterEnding":"2024/09","expectedEps":-0.56,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"post","actualEps":-0.42},{"market":"US","date":"2024-08-08","symbol":"LTRN","fiscalQuarterEnding":"2024/06","expectedEps":-0.55,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723089600000,"reportTimeType":"post","actualEps":-0.46},{"market":"US","date":"2024-05-09","symbol":"LTRN","fiscalQuarterEnding":"2024/03","expectedEps":-0.43,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"post","actualEps":-0.51},{"market":"US","date":"2024-03-18","symbol":"LTRN","fiscalQuarterEnding":"2023/12","expectedEps":-0.4,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1710734400000,"reportTimeType":"post","actualEps":-0.39}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LTRN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LTRN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1743825600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LTRN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LTRN","date":"2025-04-21","current":-1.774861,"percent":0.985798,"low":-49.754346,"twenty":-21.653107,"median":-4.143336,"eighty":-2.862346,"high":-1.33893,"avg":-10.801346,"sd":11.852571,"marketCap":36883759},"quantilePoints":[{"date":"2020-06-05","current":-39.359566,"twenty":-39.359566,"median":-39.359566,"eighty":-39.359566,"marketCap":96489504},{"date":"2020-06-12","current":-37.409733,"twenty":-39.359566,"median":-38.38465,"eighty":-36.899593,"marketCap":91709511},{"date":"2020-06-19","current":-33.224824,"twenty":-39.359566,"median":-36.899593,"eighty":-32.920529,"marketCap":81450258},{"date":"2020-06-26","current":-29.67408,"twenty":-38.579633,"median":-33.465813,"eighty":-30.394407,"marketCap":72745650},{"date":"2020-07-02","current":-33.300912,"twenty":-37.374225,"median":-33.123374,"eighty":-30.465455,"marketCap":81636786},{"date":"2020-07-10","current":-32.184964,"twenty":-37.165675,"median":-33.1741,"eighty":-30.790028,"marketCap":78901052},{"date":"2020-07-17","current":-33.478449,"twenty":-36.899593,"median":-32.933157,"eighty":-31.368191,"marketCap":82072016},{"date":"2020-07-24","current":-31.851447,"twenty":-36.261035,"median":-32.793662,"eighty":-31.345466,"marketCap":78083440},{"date":"2020-07-31","current":-28.842302,"twenty":-33.661132,"median":-32.540038,"eighty":-31.053798,"marketCap":76591222},{"date":"2020-08-07","current":-27.394157,"twenty":-33.453087,"median":-32.210326,"eighty":-29.81611,"marketCap":72745650},{"date":"2020-08-14","current":-25.240087,"twenty":-33.341492,"median":-32.077173,"eighty":-28.986296,"marketCap":67025480},{"date":"2020-08-21","current":-38.866924,"twenty":-33.661132,"median":-32.083514,"eighty":-28.857053,"marketCap":103211778},{"date":"2020-08-28","current":-39.967373,"twenty":-36.511038,"median":-32.223007,"eighty":-28.986296,"marketCap":106134039},{"date":"2020-09-04","current":-33.24761,"twenty":-36.899593,"median":-32.66685,"eighty":-29.267466,"marketCap":88289593},{"date":"2020-09-11","current":-45.04817,"twenty":-36.899593,"median":-32.793662,"eighty":-29.26828,"marketCap":119626181},{"date":"2020-09-18","current":-38.562545,"twenty":-38.866924,"median":-32.9712,"eighty":-29.290676,"marketCap":102403493},{"date":"2020-09-25","current":-42.987755,"twenty":-39.359566,"median":-33.224824,"eighty":-29.67408,"marketCap":114154713},{"date":"2020-10-02","current":-47.998076,"twenty":-39.382028,"median":-33.274261,"eighty":-30.384229,"marketCap":127459706},{"date":"2020-10-09","current":-47.085171,"twenty":-40.388822,"median":-33.478449,"eighty":-30.409674,"marketCap":125035473},{"date":"2020-10-16","current":-46.312516,"twenty":-41.770236,"median":-33.711344,"eighty":-30.688578,"marketCap":122983673},{"date":"2020-10-23","current":-40.974167,"twenty":-41.465857,"median":-34.558783,"eighty":-31.01829,"marketCap":108807597},{"date":"2020-10-30","current":-25.461466,"twenty":-41.442443,"median":-34.757801,"eighty":-30.688578,"marketCap":93885412},{"date":"2020-11-06","current":-27.569203,"twenty":-41.184891,"median":-33.715886,"eighty":-29.290676,"marketCap":101657383},{"date":"2020-11-13","current":-25.832427,"twenty":-40.974167,"median":-33.491805,"eighty":-28.916055,"marketCap":95253279},{"date":"2020-11-20","current":-27.063346,"twenty":-40.974167,"median":-33.300912,"eighty":-28.479745,"marketCap":99792110},{"date":"2020-11-27","current":-27.653512,"twenty":-40.974167,"median":-33.224824,"eighty":-27.569203,"marketCap":101968262},{"date":"2020-12-04","current":-25.798704,"twenty":-40.936705,"median":-33.098013,"eighty":-27.140684,"marketCap":95128928},{"date":"2020-12-11","current":-30.941582,"twenty":-40.496525,"median":-32.844388,"eighty":-26.678895,"marketCap":114092537},{"date":"2020-12-18","current":-31.44744,"twenty":-40.295167,"median":-32.692257,"eighty":-26.989154,"marketCap":115957811},{"date":"2020-12-24","current":-32.290534,"twenty":-40.229608,"median":-32.427759,"eighty":-27.12135,"marketCap":119066599},{"date":"2020-12-31","current":-32.459153,"twenty":-40.107856,"median":-32.526601,"eighty":-27.182053,"marketCap":119688357},{"date":"2021-01-08","current":-31.852125,"twenty":-39.901815,"median":-32.413226,"eighty":-27.286725,"marketCap":117450029},{"date":"2021-01-15","current":-24.179962,"twenty":-39.634897,"median":-32.24625,"eighty":-27.102015,"marketCap":89160054},{"date":"2021-01-22","current":-25.984185,"twenty":-39.377536,"median":-32.197645,"eighty":-26.635054,"marketCap":95812861},{"date":"2021-01-29","current":-25.343433,"twenty":-39.359566,"median":-32.083514,"eighty":-26.232054,"marketCap":93450182},{"date":"2021-02-05","current":-29.069912,"twenty":-39.359566,"median":-32.047625,"eighty":-26.206761,"marketCap":107191027},{"date":"2021-02-12","current":-31.127064,"twenty":-39.359566,"median":-32.037606,"eighty":-26.232054,"marketCap":114776471},{"date":"2021-02-19","current":-32.526601,"twenty":-39.359566,"median":-31.852125,"eighty":-26.279268,"marketCap":119937060},{"date":"2021-02-26","current":-29.963593,"twenty":-39.007407,"median":-31.641351,"eighty":-26.504432,"marketCap":110486343},{"date":"2021-03-05","current":-25.208537,"twenty":-38.866924,"median":-31.436771,"eighty":-26.279268,"marketCap":92952776},{"date":"2021-03-12","current":-35.863529,"twenty":-38.866924,"median":-31.442106,"eighty":-26.279268,"marketCap":211888545},{"date":"2021-03-19","current":-40.230675,"twenty":-39.007407,"median":-31.835263,"eighty":-26.504432,"marketCap":237690471},{"date":"2021-03-26","current":-35.371989,"twenty":-39.007407,"median":-31.868987,"eighty":-26.523765,"marketCap":208984432},{"date":"2021-04-01","current":-37.602825,"twenty":-38.895021,"median":-32.047625,"eighty":-26.523765,"marketCap":222164636},{"date":"2021-04-09","current":-32.381247,"twenty":-38.866924,"median":-32.083514,"eighty":-26.604703,"marketCap":191314558},{"date":"2021-04-16","current":-29.258566,"twenty":-38.866924,"median":-32.047625,"eighty":-26.665406,"marketCap":172865170},{"date":"2021-04-23","current":-31.321428,"twenty":-38.698345,"median":-31.852125,"eighty":-26.689012,"marketCap":185052947},{"date":"2021-04-30","current":-28.406926,"twenty":-38.581276,"median":-31.656371,"eighty":-26.894727,"marketCap":167833519},{"date":"2021-05-07","current":-22.155216,"twenty":-38.248499,"median":-31.436771,"eighty":-26.523765,"marketCap":174654202},{"date":"2021-05-14","current":-18.353937,"twenty":-37.716257,"median":-31.351316,"eighty":-26.216879,"marketCap":144687924},{"date":"2021-05-21","current":-20.552438,"twenty":-37.508972,"median":-31.195828,"eighty":-26.149432,"marketCap":162019167},{"date":"2021-05-28","current":-21.446023,"twenty":-37.424888,"median":-31.101771,"eighty":-26.017909,"marketCap":169063478},{"date":"2021-06-04","current":-21.524034,"twenty":-37.366783,"median":-31.022091,"eighty":-25.930125,"marketCap":169678458},{"date":"2021-06-11","current":-22.098481,"twenty":-37.274577,"median":-30.941582,"eighty":-25.818938,"marketCap":174206944},{"date":"2021-06-18","current":-21.403471,"twenty":-37.227708,"median":-30.614831,"eighty":-25.738872,"marketCap":168728035},{"date":"2021-06-25","current":-21.644597,"twenty":-37.029643,"median":-30.431937,"eighty":-25.62334,"marketCap":170628881},{"date":"2021-07-02","current":-20.708461,"twenty":-36.899593,"median":-30.384684,"eighty":-25.476146,"marketCap":163249126},{"date":"2021-07-09","current":-20.33968,"twenty":-36.890456,"median":-30.352795,"eighty":-25.221157,"marketCap":160341949},{"date":"2021-07-16","current":-18.439041,"twenty":-36.864694,"median":-30.182797,"eighty":-24.793735,"marketCap":145358811},{"date":"2021-07-23","current":-19.531199,"twenty":-36.581934,"median":-30.078022,"eighty":-22.705551,"marketCap":153968525},{"date":"2021-07-30","current":-15.403585,"twenty":-36.105763,"median":-29.947911,"eighty":-22.138196,"marketCap":144274103},{"date":"2021-08-06","current":-16.346905,"twenty":-35.960314,"median":-29.731278,"eighty":-21.726863,"marketCap":153109493},{"date":"2021-08-13","current":-15.045362,"twenty":-35.897559,"median":-29.424012,"eighty":-21.566586,"marketCap":140918891},{"date":"2021-08-20","current":-13.636352,"twenty":-35.725617,"median":-29.281466,"eighty":-21.409145,"marketCap":127721725},{"date":"2021-08-27","current":-16.788713,"twenty":-35.490294,"median":-29.267262,"eighty":-21.278653,"marketCap":157247588},{"date":"2021-09-03","current":-16.955884,"twenty":-35.417362,"median":-29.086774,"eighty":-21.074405,"marketCap":158813353},{"date":"2021-09-10","current":-16.10809,"twenty":-35.363879,"median":-29.010896,"eighty":-20.824769,"marketCap":150872686},{"date":"2021-09-17","current":-14.125923,"twenty":-35.256515,"median":-28.916055,"eighty":-20.685767,"marketCap":132307181},{"date":"2021-09-24","current":-14.531909,"twenty":-34.881047,"median":-28.820644,"eighty":-20.50705,"marketCap":136109754},{"date":"2021-10-01","current":-12.776617,"twenty":-34.574126,"median":-28.611675,"eighty":-20.294292,"marketCap":119669217},{"date":"2021-10-08","current":-13.182603,"twenty":-34.544735,"median":-28.462884,"eighty":-19.760978,"marketCap":123471790},{"date":"2021-10-15","current":-11.952704,"twenty":-34.44971,"median":-27.952719,"eighty":-19.576588,"marketCap":111952230},{"date":"2021-10-22","current":-12.036289,"twenty":-34.275477,"median":-27.705292,"eighty":-19.20497,"marketCap":112735113},{"date":"2021-10-29","current":-12.191519,"twenty":-34.173387,"median":-27.569203,"eighty":-18.370958,"marketCap":114189038},{"date":"2021-11-05","current":-9.842875,"twenty":-33.997191,"median":-27.187561,"eighty":-17.888706,"marketCap":115346279},{"date":"2021-11-12","current":-9.308247,"twenty":-33.714069,"median":-26.945313,"eighty":-16.795878,"marketCap":109081108},{"date":"2021-11-19","current":-8.582681,"twenty":-33.666475,"median":-26.65023,"eighty":-16.497358,"marketCap":100578375},{"date":"2021-11-26","current":-8.554041,"twenty":-33.505162,"median":-26.523765,"eighty":-16.346905,"marketCap":100242741},{"date":"2021-12-03","current":-7.2843,"twenty":-33.504591,"median":-26.279268,"eighty":-15.928978,"marketCap":85362959},{"date":"2021-12-10","current":-7.704365,"twenty":-33.478449,"median":-26.194958,"eighty":-15.475229,"marketCap":90285594},{"date":"2021-12-17","current":-7.341582,"twenty":-33.351637,"median":-26.152804,"eighty":-15.105066,"marketCap":86034228},{"date":"2021-12-23","current":-6.978799,"twenty":-33.311057,"median":-26.11908,"eighty":-14.656093,"marketCap":81782861},{"date":"2021-12-31","current":-7.618442,"twenty":-33.25827,"median":-26.017909,"eighty":-14.381456,"marketCap":89278691},{"date":"2022-01-07","current":-6.711485,"twenty":-33.229381,"median":-25.950292,"eighty":-14.202344,"marketCap":78650276},{"date":"2022-01-14","current":-6.940611,"twenty":-33.224824,"median":-25.874582,"eighty":-13.674562,"marketCap":81335349},{"date":"2022-01-21","current":-5.842715,"twenty":-33.19439,"median":-25.815565,"eighty":-13.464405,"marketCap":68469372},{"date":"2022-01-28","current":-6.033654,"twenty":-33.082795,"median":-25.798704,"eighty":-13.165886,"marketCap":70706933},{"date":"2022-02-04","current":-6.434624,"twenty":-33.00801,"median":-25.714394,"eighty":-12.7599,"marketCap":75405812},{"date":"2022-02-11","current":-6.596922,"twenty":-32.951779,"median":-25.630085,"eighty":-12.36182,"marketCap":77307739},{"date":"2022-02-18","current":-6.377343,"twenty":-32.874823,"median":-25.571068,"eighty":-12.213013,"marketCap":74734544},{"date":"2022-02-25","current":-6.100482,"twenty":-32.824098,"median":-25.473699,"eighty":-12.067335,"marketCap":71490080},{"date":"2022-03-04","current":-5.346275,"twenty":-32.763263,"median":-25.240087,"eighty":-11.589705,"marketCap":62651713},{"date":"2022-03-11","current":-5.964441,"twenty":-32.697339,"median":-25.054193,"eighty":-9.89061,"marketCap":73738551},{"date":"2022-03-18","current":-6.06908,"twenty":-32.63773,"median":-24.78699,"eighty":-9.669121,"marketCap":75032210},{"date":"2022-03-25","current":-6.226039,"twenty":-32.56707,"median":-23.472542,"eighty":-9.273878,"marketCap":76972698},{"date":"2022-04-01","current":-6.304518,"twenty":-32.507746,"median":-22.665836,"eighty":-8.714429,"marketCap":77942942},{"date":"2022-04-08","current":-6.11268,"twenty":-32.47134,"median":-22.141033,"eighty":-8.309639,"marketCap":75571234},{"date":"2022-04-14","current":-5.99932,"twenty":-32.455781,"median":-21.970826,"eighty":-8.080514,"marketCap":74169771},{"date":"2022-04-22","current":-6.01676,"twenty":-32.436479,"median":-21.687148,"eighty":-7.763555,"marketCap":74385381},{"date":"2022-04-29","current":-5.22141,"twenty":-32.411349,"median":-21.637505,"eighty":-7.50388,"marketCap":64552444},{"date":"2022-05-06","current":-4.746858,"twenty":-32.399323,"median":-21.446023,"eighty":-7.295756,"marketCap":66610324},{"date":"2022-05-13","current":-4.515304,"twenty":-32.363104,"median":-21.410563,"eighty":-7.230838,"marketCap":63361039},{"date":"2022-05-20","current":-4.631081,"twenty":-32.283789,"median":-21.375103,"eighty":-7.138233,"marketCap":64985682},{"date":"2022-05-27","current":-4.330061,"twenty":-32.252586,"median":-21.21908,"eighty":-7.009349,"marketCap":60761612},{"date":"2022-06-03","current":-4.413883,"twenty":-32.235688,"median":-21.112702,"eighty":-6.91197,"marketCap":61937853},{"date":"2022-06-10","current":-4.160254,"twenty":-32.210326,"median":-21.03469,"eighty":-6.740126,"marketCap":58378804},{"date":"2022-06-17","current":-3.755035,"twenty":-32.184964,"median":-20.786473,"eighty":-6.654203,"marketCap":52692557},{"date":"2022-06-24","current":-3.890108,"twenty":-32.161504,"median":-20.708461,"eighty":-6.500434,"marketCap":54587972},{"date":"2022-07-01","current":-4.337779,"twenty":-32.115171,"median":-20.665909,"eighty":-6.423168,"marketCap":60869922},{"date":"2022-07-08","current":-4.468993,"twenty":-32.094937,"median":-20.552438,"eighty":-6.333427,"marketCap":62711183},{"date":"2022-07-15","current":-4.160254,"twenty":-32.085385,"median":-20.424784,"eighty":-6.243603,"marketCap":58378804},{"date":"2022-07-22","current":-3.897827,"twenty":-32.075905,"median":-20.282945,"eighty":-6.231271,"marketCap":54696282},{"date":"2022-07-29","current":-3.959574,"twenty":-32.062919,"median":-19.775871,"eighty":-6.154674,"marketCap":55562758},{"date":"2022-08-05","current":-4.214284,"twenty":-32.045621,"median":-19.71559,"eighty":-6.100482,"marketCap":59136970},{"date":"2022-08-12","current":-4.266648,"twenty":-31.946552,"median":-19.580843,"eighty":-6.074312,"marketCap":69155596},{"date":"2022-08-19","current":-3.742088,"twenty":-31.865615,"median":-19.531199,"eighty":-6.039432,"marketCap":60653303},{"date":"2022-08-26","current":-3.802295,"twenty":-31.851718,"median":-19.048947,"eighty":-6.008464,"marketCap":61629171},{"date":"2022-09-02","current":-3.474796,"twenty":-31.841737,"median":-18.439041,"eighty":-5.953459,"marketCap":56320924},{"date":"2022-09-09","current":-3.563002,"twenty":-31.692149,"median":-18.311386,"eighty":-5.923279,"marketCap":57750609},{"date":"2022-09-16","current":-3.347832,"twenty":-31.465463,"median":-17.956789,"eighty":-5.846534,"marketCap":54263044},{"date":"2022-09-23","current":-3.16741,"twenty":-31.443172,"median":-16.955884,"eighty":-5.814926,"marketCap":51338688},{"date":"2022-09-30","current":-3.194139,"twenty":-31.421553,"median":-16.681247,"eighty":-5.711562,"marketCap":51771926},{"date":"2022-10-07","current":-3.374561,"twenty":-31.391233,"median":-16.526016,"eighty":-5.645613,"marketCap":54696282},{"date":"2022-10-14","current":-3.214186,"twenty":-31.357051,"median":-16.382728,"eighty":-5.408473,"marketCap":52096855},{"date":"2022-10-21","current":-3.133998,"twenty":-31.322155,"median":-16.299142,"eighty":-5.121538,"marketCap":50797141},{"date":"2022-10-28","current":-2.873389,"twenty":-31.271188,"median":-15.95883,"eighty":-4.705178,"marketCap":46573072},{"date":"2022-11-04","current":-2.873389,"twenty":-31.195301,"median":-15.582696,"eighty":-4.573964,"marketCap":46573072},{"date":"2022-11-11","current":-3.53139,"twenty":-31.167532,"median":-15.439407,"eighty":-4.510673,"marketCap":50919517},{"date":"2022-11-18","current":-4.005756,"twenty":-31.10683,"median":-15.140888,"eighty":-4.48443,"marketCap":57759452},{"date":"2022-11-25","current":-3.802456,"twenty":-31.066361,"median":-15.045362,"eighty":-4.468993,"marketCap":54828052},{"date":"2022-12-02","current":-3.840104,"twenty":-31.024372,"median":-14.627435,"eighty":-4.414099,"marketCap":55370904},{"date":"2022-12-09","current":-3.960578,"twenty":-31.016438,"median":-14.424442,"eighty":-4.387177,"marketCap":57108030},{"date":"2022-12-16","current":-4.322,"twenty":-30.99554,"median":-14.299065,"eighty":-4.362479,"marketCap":62319409},{"date":"2022-12-23","current":-4.231644,"twenty":-30.890981,"median":-14.221449,"eighty":-4.331605,"marketCap":61016564},{"date":"2022-12-30","current":-4.547888,"twenty":-30.688578,"median":-13.958752,"eighty":-4.322,"marketCap":65576521},{"date":"2023-01-06","current":-4.178937,"twenty":-30.664948,"median":-13.684115,"eighty":-4.2961,"marketCap":60256572},{"date":"2023-01-13","current":-4.12623,"twenty":-30.588305,"median":-13.582618,"eighty":-4.228632,"marketCap":59496579},{"date":"2023-01-20","current":-3.9154,"twenty":-30.498766,"median":-13.278129,"eighty":-4.214284,"marketCap":56456608},{"date":"2023-01-27","current":-4.005756,"twenty":-30.439507,"median":-13.170662,"eighty":-4.193895,"marketCap":57759452},{"date":"2023-02-03","current":-4.299411,"twenty":-30.418579,"median":-12.901995,"eighty":-4.200454,"marketCap":61993698},{"date":"2023-02-10","current":-4.465062,"twenty":-30.394954,"median":-12.752735,"eighty":-4.206043,"marketCap":64382247},{"date":"2023-02-17","current":-4.103641,"twenty":-30.384593,"median":-12.472746,"eighty":-4.181621,"marketCap":59170868},{"date":"2023-02-24","current":-3.9154,"twenty":-30.377849,"median":-12.340779,"eighty":-4.153392,"marketCap":56456608},{"date":"2023-03-03","current":-4.171407,"twenty":-30.355891,"median":-12.227342,"eighty":-4.141289,"marketCap":60148001},{"date":"2023-03-10","current":-3.23766,"twenty":-30.329741,"median":-12.125845,"eighty":-4.12749,"marketCap":46684186},{"date":"2023-03-17","current":-3.576568,"twenty":-30.26415,"median":-12.036289,"eighty":-4.099206,"marketCap":51570940},{"date":"2023-03-24","current":-3.437568,"twenty":-30.176471,"median":-11.648214,"eighty":-4.081052,"marketCap":49019535},{"date":"2023-03-31","current":-3.677398,"twenty":-30.136702,"median":-11.200436,"eighty":-4.068388,"marketCap":52439503},{"date":"2023-04-06","current":-3.761149,"twenty":-30.085978,"median":-9.852422,"eighty":-4.059969,"marketCap":53633777},{"date":"2023-04-14","current":-3.844899,"twenty":-30.04453,"median":-9.709218,"eighty":-4.007326,"marketCap":54828052},{"date":"2023-04-21","current":-3.738308,"twenty":-29.963593,"median":-9.594655,"eighty":-3.990697,"marketCap":53308066},{"date":"2023-04-28","current":-3.631716,"twenty":-29.947911,"median":-9.308247,"eighty":-3.990448,"marketCap":51788080},{"date":"2023-05-05","current":-3.806831,"twenty":-29.920953,"median":-9.126856,"eighty":-3.962604,"marketCap":54285200},{"date":"2023-05-12","current":-4.178189,"twenty":-29.788476,"median":-8.668604,"eighty":-3.962604,"marketCap":58519445},{"date":"2023-05-19","current":-3.643318,"twenty":-29.67408,"median":-8.491986,"eighty":-3.960578,"marketCap":51028088},{"date":"2023-05-26","current":-3.674325,"twenty":-29.474597,"median":-8.219898,"eighty":-3.959574,"marketCap":51462369},{"date":"2023-06-02","current":-4.116175,"twenty":-29.434129,"median":-8.057601,"eighty":-3.958337,"marketCap":57650882},{"date":"2023-06-09","current":-4.255706,"twenty":-29.397638,"median":-7.857115,"eighty":-3.95332,"marketCap":59605149},{"date":"2023-06-16","current":-4.581279,"twenty":-29.31075,"median":-7.704365,"eighty":-3.958337,"marketCap":64165106},{"date":"2023-06-23","current":-4.13943,"twenty":-29.279623,"median":-7.618442,"eighty":-3.959574,"marketCap":57976593},{"date":"2023-06-30","current":-3.992147,"twenty":-29.270665,"median":-7.456145,"eighty":-3.959976,"marketCap":55913756},{"date":"2023-07-07","current":-3.96114,"twenty":-29.268076,"median":-7.341582,"eighty":-3.960578,"marketCap":55479474},{"date":"2023-07-14","current":-4.030905,"twenty":-29.265523,"median":-7.269979,"eighty":-3.959775,"marketCap":56456608},{"date":"2023-07-21","current":-3.643318,"twenty":-29.224208,"median":-7.227019,"eighty":-3.953116,"marketCap":51028088},{"date":"2023-07-28","current":-3.488284,"twenty":-29.086774,"median":-7.181671,"eighty":-3.941001,"marketCap":48856680},{"date":"2023-08-04","current":-3.658822,"twenty":-29.083402,"median":-7.083815,"eighty":-3.9154,"marketCap":51245228},{"date":"2023-08-11","current":-3.80683,"twenty":-29.046305,"median":-7.012213,"eighty":-3.903079,"marketCap":54285200},{"date":"2023-08-18","current":-3.285114,"twenty":-28.94887,"median":-6.940611,"eighty":-3.893814,"marketCap":46845562},{"date":"2023-08-25","current":-3.582375,"twenty":-28.93268,"median":-6.768766,"eighty":-3.88239,"marketCap":51084488},{"date":"2023-09-01","current":-3.445178,"twenty":-28.906358,"median":-6.740126,"eighty":-3.874911,"marketCap":49128060},{"date":"2023-09-08","current":-3.361335,"twenty":-28.867569,"median":-6.701938,"eighty":-3.859234,"marketCap":47932466},{"date":"2023-09-15","current":-3.193649,"twenty":-28.842302,"median":-6.625563,"eighty":-3.847634,"marketCap":45541277},{"date":"2023-09-22","current":-2.8659,"twenty":-28.816312,"median":-6.511,"eighty":-3.842981,"marketCap":40867590},{"date":"2023-09-29","current":-2.629616,"twenty":-28.728847,"median":-6.484585,"eighty":-3.822188,"marketCap":37498188},{"date":"2023-10-06","current":-2.416198,"twenty":-28.668005,"median":-6.453718,"eighty":-3.818334,"marketCap":34454856},{"date":"2023-10-13","current":-2.431442,"twenty":-28.608896,"median":-6.372569,"eighty":-3.808049,"marketCap":34672237},{"date":"2023-10-20","current":-2.355221,"twenty":-28.574172,"median":-6.310514,"eighty":-3.80683,"marketCap":33585333},{"date":"2023-10-27","current":-2.103693,"twenty":-28.526959,"median":-6.304518,"eighty":-3.802392,"marketCap":29998550},{"date":"2023-11-03","current":-2.088448,"twenty":-28.459511,"median":-6.243583,"eighty":-3.796462,"marketCap":29781169},{"date":"2023-11-10","current":-2.674822,"twenty":-28.422564,"median":-6.234759,"eighty":-3.786034,"marketCap":40541519},{"date":"2023-11-17","current":-2.760875,"twenty":-28.134402,"median":-6.215769,"eighty":-3.775032,"marketCap":41845804},{"date":"2023-11-24","current":-2.891389,"twenty":-27.886995,"median":-6.18163,"eighty":-3.764808,"marketCap":43823969},{"date":"2023-12-01","current":-2.832586,"twenty":-27.775873,"median":-6.121399,"eighty":-3.757481,"marketCap":42932708},{"date":"2023-12-08","current":-2.696335,"twenty":-27.715647,"median":-6.100482,"eighty":-3.742088,"marketCap":40867590},{"date":"2023-12-15","current":-2.976008,"twenty":-27.619788,"median":-6.08652,"eighty":-3.728574,"marketCap":45106516},{"date":"2023-12-22","current":-2.92581,"twenty":-27.569203,"median":-6.060914,"eighty":-3.710855,"marketCap":44345683},{"date":"2023-12-29","current":-3.148115,"twenty":-27.569203,"median":-6.04292,"eighty":-3.682077,"marketCap":47715085},{"date":"2024-01-05","current":-2.997521,"twenty":-27.464175,"median":-6.03856,"eighty":-3.676169,"marketCap":45432587},{"date":"2024-01-12","current":-2.897126,"twenty":-27.286725,"median":-6.01676,"eighty":-3.652498,"marketCap":43910921},{"date":"2024-01-19","current":-2.753704,"twenty":-27.193069,"median":-5.99932,"eighty":-3.636357,"marketCap":41737113},{"date":"2024-01-26","current":-3.004693,"twenty":-27.12135,"median":-5.960859,"eighty":-3.595258,"marketCap":45541277},{"date":"2024-02-02","current":-3.033377,"twenty":-27.016133,"median":-5.947001,"eighty":-3.581467,"marketCap":45976039},{"date":"2024-02-09","current":-2.976008,"twenty":-26.844141,"median":-5.899997,"eighty":-3.557152,"marketCap":45106516},{"date":"2024-02-16","current":-2.875613,"twenty":-26.68564,"median":-5.852262,"eighty":-3.548697,"marketCap":43584850},{"date":"2024-02-23","current":-2.775217,"twenty":-26.665406,"median":-5.842715,"eighty":-3.544265,"marketCap":42063184},{"date":"2024-03-01","current":-3.449301,"twenty":-26.604703,"median":-5.815138,"eighty":-3.535733,"marketCap":52280082},{"date":"2024-03-08","current":-4.768784,"twenty":-26.523765,"median":-5.720282,"eighty":-3.534794,"marketCap":72279116},{"date":"2024-03-15","current":-5.270761,"twenty":-26.519898,"median":-5.711562,"eighty":-3.534822,"marketCap":79887444},{"date":"2024-03-22","current":-6.076744,"twenty":-26.459399,"median":-5.720282,"eighty":-3.535733,"marketCap":96994155},{"date":"2024-03-28","current":-6.581457,"twenty":-26.279268,"median":-5.814075,"eighty":-3.53892,"marketCap":105050148},{"date":"2024-04-05","current":-4.858703,"twenty":-26.220251,"median":-5.815247,"eighty":-3.540353,"marketCap":77552359},{"date":"2024-04-12","current":-4.488581,"twenty":-26.203389,"median":-5.798762,"eighty":-3.544265,"marketCap":71644631},{"date":"2024-04-19","current":-3.882925,"twenty":-26.186527,"median":-5.711562,"eighty":-3.544265,"marketCap":61977439},{"date":"2024-04-26","current":-3.67431,"twenty":-26.152804,"median":-5.676682,"eighty":-3.547966,"marketCap":58647629},{"date":"2024-05-03","current":-3.700511,"twenty":-26.152804,"median":-5.592109,"eighty":-3.544265,"marketCap":59065839},{"date":"2024-05-10","current":-4.590252,"twenty":-26.135942,"median":-5.449964,"eighty":-3.547966,"marketCap":73267462},{"date":"2024-05-17","current":-3.767359,"twenty":-26.11908,"median":-5.375831,"eighty":-3.548301,"marketCap":66059062},{"date":"2024-05-24","current":-3.822581,"twenty":-26.102218,"median":-5.270761,"eighty":-3.54929,"marketCap":67027355},{"date":"2024-05-31","current":-3.865532,"twenty":-26.034771,"median":-5.222097,"eighty":-3.551368,"marketCap":67780471},{"date":"2024-06-07","current":-3.564879,"twenty":-26.017909,"median":-5.215024,"eighty":-3.554841,"marketCap":62508657},{"date":"2024-06-14","current":-3.337856,"twenty":-25.997675,"median":-5.047678,"eighty":-3.548167,"marketCap":58527899},{"date":"2024-06-21","current":-2.724279,"twenty":-25.970628,"median":-4.921059,"eighty":-3.541918,"marketCap":47769094},{"date":"2024-06-28","current":-2.785637,"twenty":-25.957071,"median":-4.879965,"eighty":-3.538123,"marketCap":48844974},{"date":"2024-07-05","current":-2.632243,"twenty":-25.920042,"median":-4.773258,"eighty":-3.534794,"marketCap":46155273},{"date":"2024-07-12","current":-2.577021,"twenty":-25.889758,"median":-4.677392,"eighty":-3.524417,"marketCap":45186981},{"date":"2024-07-15","current":-2.712008,"twenty":-25.886385,"median":-4.672877,"eighty":-3.516764,"marketCap":47553918},{"date":"2024-08-02","current":-2.49112,"twenty":-25.883013,"median":-4.668362,"eighty":-3.513777,"marketCap":43680748},{"date":"2024-08-09","current":-2.595428,"twenty":-25.866151,"median":-4.656049,"eighty":-3.486212,"marketCap":45509745},{"date":"2024-08-16","current":-2.602067,"twenty":-25.832427,"median":-4.631081,"eighty":-3.47183,"marketCap":46180670},{"date":"2024-08-23","current":-2.559609,"twenty":-25.798704,"median":-4.597393,"eighty":-3.454749,"marketCap":45427139},{"date":"2024-08-30","current":-2.450431,"twenty":-25.798704,"median":-4.580911,"eighty":-3.437634,"marketCap":43489489},{"date":"2024-09-06","current":-2.122898,"twenty":-25.798704,"median":-4.569333,"eighty":-3.425531,"marketCap":37676537},{"date":"2024-09-13","current":-2.298796,"twenty":-25.763894,"median":-4.550892,"eighty":-3.410889,"marketCap":40798307},{"date":"2024-09-20","current":-2.468628,"twenty":-25.722553,"median":-4.532829,"eighty":-3.385253,"marketCap":43812430},{"date":"2024-09-27","current":-2.329123,"twenty":-25.714394,"median":-4.518517,"eighty":-3.364857,"marketCap":41336544},{"date":"2024-10-04","current":-2.183553,"twenty":-25.660436,"median":-4.507586,"eighty":-3.349575,"marketCap":38753010},{"date":"2024-10-11","current":-2.056179,"twenty":-25.633457,"median":-4.492149,"eighty":-3.345103,"marketCap":36492417},{"date":"2024-10-18","current":-2.056179,"twenty":-25.616595,"median":-4.48443,"eighty":-3.321099,"marketCap":36492417},{"date":"2024-10-25","current":-2.092571,"twenty":-25.586244,"median":-4.468993,"eighty":-3.300188,"marketCap":37138301},{"date":"2024-10-31","current":-1.977328,"twenty":-25.569382,"median":-4.468993,"eighty":-3.280799,"marketCap":35093003},{"date":"2024-11-08","current":-2.074375,"twenty":-25.516614,"median":-4.453556,"eighty":-3.262859,"marketCap":36815359},{"date":"2024-11-15","current":-1.967789,"twenty":-25.471252,"median":-4.414423,"eighty":-3.237626,"marketCap":37568890},{"date":"2024-11-22","current":-1.666407,"twenty":-25.390646,"median":-4.399527,"eighty":-3.221873,"marketCap":31814938},{"date":"2024-11-29","current":-1.813277,"twenty":-25.302095,"median":-4.397296,"eighty":-3.196812,"marketCap":34618967},{"date":"2024-12-06","current":-1.977093,"twenty":-25.227467,"median":-4.376411,"eighty":-3.174092,"marketCap":37746537},{"date":"2024-12-13","current":-2.050528,"twenty":-25.147834,"median":-4.367817,"eighty":-3.139645,"marketCap":39148551},{"date":"2024-12-20","current":-1.813277,"twenty":-25.05471,"median":-4.348356,"eighty":-3.094682,"marketCap":34618967},{"date":"2024-12-27","current":-1.988391,"twenty":-25.002055,"median":-4.337419,"eighty":-3.077838,"marketCap":37962232},{"date":"2025-01-03","current":-1.864117,"twenty":-24.803852,"median":-4.33356,"eighty":-3.053811,"marketCap":35589592},{"date":"2025-01-10","current":-2.214345,"twenty":-24.790362,"median":-4.324687,"eighty":-3.033377,"marketCap":42276122},{"date":"2025-01-17","current":-2.033582,"twenty":-24.530689,"median":-4.300154,"eighty":-3.018391,"marketCap":38825010},{"date":"2025-01-24","current":-2.355566,"twenty":-24.294623,"median":-4.299187,"eighty":-3.008996,"marketCap":44972303},{"date":"2025-01-31","current":-2.717091,"twenty":-23.331059,"median":-4.280286,"eighty":-3.000867,"marketCap":51874527},{"date":"2025-02-07","current":-2.993884,"twenty":-22.705551,"median":-4.269116,"eighty":-2.987482,"marketCap":57159042},{"date":"2025-02-14","current":-2.728389,"twenty":-22.665836,"median":-4.259678,"eighty":-2.976008,"marketCap":52090221},{"date":"2025-02-21","current":-2.445947,"twenty":-22.484282,"median":-4.247217,"eighty":-2.968837,"marketCap":46697859},{"date":"2025-02-28","current":-2.253886,"twenty":-22.189258,"median":-4.231644,"eighty":-2.952498,"marketCap":43031052},{"date":"2025-03-07","current":-2.197398,"twenty":-22.143869,"median":-4.214284,"eighty":-2.93585,"marketCap":41952580},{"date":"2025-03-14","current":-2.112666,"twenty":-22.115502,"median":-4.209055,"eighty":-2.92581,"marketCap":40334871},{"date":"2025-03-21","current":-2.101368,"twenty":-21.996357,"median":-4.192657,"eighty":-2.899677,"marketCap":40119177},{"date":"2025-03-28","current":-2.101368,"twenty":-21.820477,"median":-4.18341,"eighty":-2.890529,"marketCap":40119177},{"date":"2025-04-04","current":-1.686637,"twenty":-21.746721,"median":-4.174798,"eighty":-2.875613,"marketCap":35050356},{"date":"2025-04-11","current":-1.577654,"twenty":-21.675801,"median":-4.160254,"eighty":-2.868896,"marketCap":32785564},{"date":"2025-04-17","current":-1.811188,"twenty":-21.655944,"median":-4.145382,"eighty":-2.864249,"marketCap":37638690},{"date":"2025-04-21","current":-1.774861,"twenty":-21.653107,"median":-4.143336,"eighty":-2.862346,"marketCap":36883759}],"updateTime":1745334547873}}}